VWF and neoplasm: Jun Ishihara and colleagues reported a fusion protein of IL-2 and vWF A3-CBD, which reduced splenomegaly and pulmonary edema induced by IL-2-related vascular leakage and improved its anti-tumor efficacy in C57BL/6 B16F10 allograft mouse model (44).